Comparative Efficacy of Traditional Triple Therapy versus Vonoprazan-Based Therapy in Helicobacter Pylori Eradication
Basuony, H., Elhossiny, I., Hassan, A., Alkherkhisy, M., Abdulrahman, M., Al-Haidary, N. (2646). Comparative Efficacy of Traditional Triple Therapy versus Vonoprazan-Based Therapy in Helicobacter Pylori Eradication. EKB Journal Management System, 2024(12), -. doi: 10.58675/2682-339X.2778
Hany Basuony; Ibrahim Elhossiny; Ayman Hassan; Mohammad Alkherkhisy; Mohammed Abdulrahman; Naif Al-Haidary. "Comparative Efficacy of Traditional Triple Therapy versus Vonoprazan-Based Therapy in Helicobacter Pylori Eradication". EKB Journal Management System, 2024, 12, 2646, -. doi: 10.58675/2682-339X.2778
Basuony, H., Elhossiny, I., Hassan, A., Alkherkhisy, M., Abdulrahman, M., Al-Haidary, N. (2646). 'Comparative Efficacy of Traditional Triple Therapy versus Vonoprazan-Based Therapy in Helicobacter Pylori Eradication', EKB Journal Management System, 2024(12), pp. -. doi: 10.58675/2682-339X.2778
Basuony, H., Elhossiny, I., Hassan, A., Alkherkhisy, M., Abdulrahman, M., Al-Haidary, N. Comparative Efficacy of Traditional Triple Therapy versus Vonoprazan-Based Therapy in Helicobacter Pylori Eradication. EKB Journal Management System, 2646; 2024(12): -. doi: 10.58675/2682-339X.2778

Comparative Efficacy of Traditional Triple Therapy versus Vonoprazan-Based Therapy in Helicobacter Pylori Eradication

Al-Azhar International Medical Journal
Volume 2024, Issue 12, December 2024  XML
DOI: 10.58675/2682-339X.2778
View on SCiNiTO View on SCiNiTO
Authors
Hany Basuony1; Ibrahim Elhossiny1; Ayman Hassan2; Mohammad Alkherkhisy1; Mohammed Abdulrahman3; Naif Al-Haidary4
1Medical Microbiology and Immunology, Faculty of Medicine for Boys, Al-Azhar University, Cairo, Egypt
2Hepatology and Gastroenterology Department, Theodor Bilharz Research Institute, Cairo, Egypt
3Microbiology and Immunology, Faculty of Pharmacy for Boys, Al-Azhar University, Cairo, Egypt
4Medical Microbiology and Immunology, Faculty of Medicine and Health Sciences, Sana’a University, Sana’a, Yemen
Abstract
Background: Gastritis, peptic ulcers, and stomach cancer are just a few of the gastrointestinal disorders that Helicobacter pylori is known to cause. Alternative medicines are now required due to the issues posed by the rising prevalence of antibiotic resistance to conventional treatment regimens. Objective: In order to eradicate H. pylori, this study compared the efficacy of vonoprazan-based therapy and conventional triple therapy, especially in areas with significant antibiotic resistance. Methods: A prospective randomized case-control study was conducted on 60 symptomatic patients confirmed to have H. pylori infection through endoscopy and biopsy. Patients were randomized into two groups: one received traditional triple therapy (clarithromycin, amoxicillin, and esomeprazole), and the other received vonoprazan-based therapy (clarithromycin, amoxicillin, and vonoprazan). Four weeks following the end of therapy, a stool antigen test was used to establish the primary result, which was the eradication rate. Results: The vonoprazan-based therapy group showed a significantly higher eradication rate (94.4%) compared to the traditional triple therapy group (44.4%). Conclusion: Vonoprazan-based therapy is more effective at eliminating H. pylori than conventional triple therapy, making it a viable substitute, particularly in regions where antibiotic resistance is prevalent.
Statistics
Article View: 15